SG Americas Securities LLC Has $53.06 Million Stock Position in Kenvue Inc. $KVUE

SG Americas Securities LLC grew its position in Kenvue Inc. (NYSE:KVUE) by 3,889.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,075,723 shares of the company’s stock after acquiring an additional 2,998,635 shares during the quarter. SG Americas Securities LLC’s holdings in Kenvue were worth $53,056,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. American Century Companies Inc. lifted its position in Kenvue by 22.4% in the third quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after purchasing an additional 6,781,640 shares during the period. Independent Franchise Partners LLP boosted its stake in Kenvue by 233.4% during the second quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after buying an additional 21,886,537 shares in the last quarter. Norges Bank bought a new stake in Kenvue in the 2nd quarter valued at $537,418,000. Dimensional Fund Advisors LP increased its holdings in Kenvue by 13.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 23,127,234 shares of the company’s stock valued at $375,377,000 after buying an additional 2,747,952 shares during the period. Finally, Van ECK Associates Corp raised its stake in shares of Kenvue by 101.3% in the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after buying an additional 9,240,434 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on KVUE. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Citigroup increased their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 18th. Barclays lifted their price objective on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Friday, March 6th. Finally, Canaccord Genuity Group upped their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Wednesday, February 18th. Three equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $19.58.

Kenvue Stock Down 0.4%

KVUE opened at $17.53 on Wednesday. The firm’s 50-day simple moving average is $17.99 and its 200-day simple moving average is $17.14. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The firm has a market cap of $33.59 billion, a price-to-earnings ratio of 22.76, a PEG ratio of 4.00 and a beta of 0.51.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period last year, the firm posted $0.26 EPS. Equities research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were issued a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.